This edition of Milliman’s South East Asia health insurance newsletter covers developments up until June 2023. We include a pharmacy briefing that details drug approvals in the United States, and also feature a Milliman article on COVID-19 and medical underwriting practices for life and health insurance. The core of the report includes market performance for Indonesia, Thailand, Malaysia, Singapore, Vietnam, the Philippines and Hong Kong. For each region, we also discuss and industry news, covering topics such as: 

• New products 
• Distribution channel
• Insurers’ initiatives
• Insurtech
• Regulatory updates